US contractor upholds Pacific Edge's Medicare ban

US contractor upholds Pacific Edge's Medicare ban
Pacific Edge has had a fresh blow to its hopes for access to the US Medicare market for Cxbladder diagnostic tests. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge’s flagship Cxbladder cancer testing has been deemed as “not considered medically reasonable and necessary” by the company’s United States Medicare administrator. The statement is in a new proposed Local Coverage Determination (LCD) for Medicare and is a fresh blow for the company’s hopes to quickly regain long-term access to the Medicare system for its bladder cancer tests.Medicare is Pacific Edge’s largest customer.The new LCD was released overnight New Zealand time by Novitas, Pacific Edge...

More Markets

Infratil, Mainfreight hit by US news flow; NZX down 2.3%
Markets Market Close

Infratil, Mainfreight hit by US news flow; NZX down 2.3%

The S&P/NZX 50 fell 2.33% to 11,836.69 points.

Gregor Thompson 22 Apr 2025
Northland council approves Marsden Maritime Holdings deal
Markets

Northland council approves Marsden Maritime Holdings deal

Ratepayers had some concerns, but councillors were unanimous. 

Ian Llewellyn 22 Apr 2025